Espinoza RT, Kellner CH (2022) Electroconvulsive therapy. N Engl J Med 386:667–672. https://doi.org/10.1056/NEJMra2034954

Article  PubMed  Google Scholar 

Semkovska M, McLoughlin DM (2010) Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 68:568–577. https://doi.org/10.1016/j.biopsych.2010.06.009

Article  PubMed  Google Scholar 

Yoldi-Negrete M, Gill LN, Olivares S, Lauziere A, Desilets M, Tourjman SV (2022) The effect of continuation and maintenance electroconvulsive therapy on cognition: a systematic review of the literature and meta-analysis. J Affect Disord 316:148–160. https://doi.org/10.1016/j.jad.2022.08.005

Article  PubMed  Google Scholar 

Hammershoj LG, Petersen JZ, Jensen HM, Jorgensen MB, Miskowiak KW (2022) Cognitive adverse effects of electroconvulsive therapy: a discrepancy between subjective and objective measures? J ECT 38:30–38. https://doi.org/10.1097/YCT.0000000000000797

Article  CAS  PubMed  Google Scholar 

Obbels J, Verwijk E, Bouckaert F, Sienaert P (2017) ECT-related anxiety: a systematic review. J ECT 33:229–236. https://doi.org/10.1097/YCT.0000000000000383

Article  PubMed  Google Scholar 

Obbels J, Gijsbregts E, Verwijk E, Verspecht S, Lambrichts S, Vansteelandt K, Sienaert P (2022) ECT-related anxiety during maintenance ECT: a prospective study. Acta Psychiatr Scand 146:604–612. https://doi.org/10.1111/acps.13496

Article  CAS  PubMed  Google Scholar 

Read J, Cunliffe S, Jauhar S, McLoughlin DM (2019) Should we stop using electroconvulsive therapy? BMJ 364:k5233. https://doi.org/10.1136/bmj.k5233

Article  PubMed  Google Scholar 

van de Mortel LA, Bruin WB, Thomas RM, Abbott C, Argyelan M, van Eijndhoven P, Mulders P, Narr KL, Tendolkar I, Verdijk J, van Waarde JA, Bartsch H, Oltedal L, van Wingen GA (2022) Multimodal multi-center analysis of electroconvulsive therapy effects in depression: brainwide gray matter increase without functional changes. Brain Stimul 15:1065–1072. https://doi.org/10.1016/j.brs.2022.07.053

Article  PubMed  Google Scholar 

Li XK, Qiu HT (2022) Current progress in neuroimaging research for the treatment of major depression with electroconvulsive therapy. World J Psychiatry 12:128–139. https://doi.org/10.5498/wjp.v12.i1.128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA (1994) Does ECT alter brain structure? Am J Psychiatry 151:957–970. https://doi.org/10.1176/ajp.151.7.957

Article  CAS  PubMed  Google Scholar 

Kranaster L, Janke C, Mindt S, Neumaier M, Sartorius A (2014) Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression. J Neural Transm (Vienna) 121:1411–1415. https://doi.org/10.1007/s00702-014-1228-9

Article  CAS  PubMed  Google Scholar 

Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E, Suhonen J, Keranen T (2010) Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: serum levels of neuron-specific enolase and S-100b protein. Psychiatry Res 177:97–100. https://doi.org/10.1016/j.psychres.2009.01.027

Article  CAS  PubMed  Google Scholar 

Ousdal OT, Brancati GE, Kessler U, Erchinger V, Dale AM, Abbott C, Oltedal L (2022) The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go? Biol Psychiatry 91:540–549. https://doi.org/10.1016/j.biopsych.2021.05.023

Article  PubMed  Google Scholar 

Xu J, Li W, Bai T, Li J, Zhang J, Hu Q, Wang J, Tian Y, Wang K (2022) Volume of hippocampus-amygdala transition area predicts outcomes of electroconvulsive therapy in major depressive disorder: high accuracy validated in two independent cohorts. Psychol Med. https://doi.org/10.1017/S0033291722001337

Article  PubMed  PubMed Central  Google Scholar 

Abu-Rumeileh S, Abdelhak A, Foschi M, D’Anna L, Russo M, Steinacker P, Kuhle J, Tumani H, Blennow K, Otto M (2022) The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain. https://doi.org/10.1093/brain/awac328

Article  Google Scholar 

Revendova KZ, Zeman D, Bunganic R, Karasova K, Volny O, Bar M, Kusnierova P (2022) Serum neurofilament levels in patients with multiple sclerosis: a comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels. Mult Scler Relat Disord 67:104177. https://doi.org/10.1016/j.msard.2022.104177

Article  CAS  PubMed  Google Scholar 

Barizzone N, Leone M, Pizzino A, Kockum I, Multiple MSC, Martinelli-Boneschi F, D’Alfonso S (2022) A scoping review on body fluid biomarkers for prognosis and disease activity in patients with multiple sclerosis. J Pers Med. https://doi.org/10.3390/jpm12091430

Article  PubMed  PubMed Central  Google Scholar 

Ahn JW, Hwang J, Lee M, Kim JH, Cho HJ, Lee HW, Eun MY (2022) Serum neurofilament light chain levels are correlated with the infarct volume in patients with acute ischemic stroke. Medicine (Baltimore) 101:e30849. https://doi.org/10.1097/MD.0000000000030849

Article  CAS  PubMed  Google Scholar 

Halbgebauer R, Halbgebauer S, Oeckl P, Steinacker P, Weihe E, Schafer MK, Roselli F, Gebhard F, Huber-Lang M, Otto M (2022) Neurochemical monitoring of traumatic brain injury by the combined analysis of plasma beta-synuclein, NfL, and GFAP in polytraumatized patients. Int J Mol Sci. https://doi.org/10.3390/ijms23179639

Article  PubMed  PubMed Central  Google Scholar 

Eratne D, Keem M, Lewis C, Kang M, Walterfang M, Farrand S, Loi S, Kelso W, Cadwallader C, Berkovic SF, Li QX, Masters CL, Collins S, Santillo A, Velakoulis D, Mi NDSG (2022) Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors. J Neurol Sci 442:120439. https://doi.org/10.1016/j.jns.2022.120439

Article  CAS  PubMed  Google Scholar 

Besse M, Belz M, Folsche T, Vogelgsang J, Methfessel I, Steinacker P, Otto M, Wiltfang J, Zilles D (2020) Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy. World J Biol Psychiatry 21:148–154. https://doi.org/10.1080/15622975.2019.1702717

Article  PubMed  Google Scholar 

Moirand R, Galvao F, Lecompte M, Poulet E, Haesebaert F, Brunelin J (2018) Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy. Psychiatry Res 259:476–481. https://doi.org/10.1016/j.psychres.2017.11.022

Article  PubMed  Google Scholar 

Shahim P, Zetterberg H, Tegner Y, Blennow K (2017) Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology 88:1788–1794. https://doi.org/10.1212/WNL.0000000000003912

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hager W (2004) Testplanung zur statistischen Prüfung psychologischer Hypothesen. Hogrefe Verlag, Göttingen

Google Scholar 

Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y, Mattsson N, Andreasen N, Ost M, Zetterberg H, Nellgard B, Blennow K (2016) Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep 6:36791. https://doi.org/10.1038/srep36791

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker E, Nowacki AS (2011) Understanding equivalence and noninferiority testing. J Gen Intern Med 26:192–196. https://doi.org/10.1007/s11606-010-1513-8

Article  PubMed  Google Scholar 

Barker LE, Luman ET, McCauley MM, Chu SY (2002) Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage. Am J Epidemiol 156:1056–1061. https://doi.org/10.1093/aje/kwf149

Article  PubMed  Google Scholar 

Kranaster L, Aksay SS, Bumb JM, Janke C, Alonso A, Hoyer C, Zerr I, Schmitz M, Hausner L, Frolich L, Sartorius A (2016) Electroconvulsive therapy selectively enhances amyloid beta 1–42 in the cerebrospinal fluid of patients with major depression: a prospective pilot study. Eur Neuropsychopharmacol 26:1877–1884. https://doi.org/10.1016/j.euroneuro.2016.11.004

Article  CAS  PubMed